New Hampshire Oncology Hematology PA-Concord is a clinical research site located in Concord, New Hampshire, United States 03301.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
New Hampshire Oncology Hematology PA-Concord has participated in 106 clinical trials with 63 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prostate Carcinoma.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New Hampshire Oncology Hematology PA-Concord has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New Hampshire Oncology Hematology PA-Concord has 106 clinical trials on record, with 63 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prostate Carcinoma.
New Hampshire Oncology Hematology PA-Concord has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.